Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.05%

More On BIOCON.NS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Biocon Limited (BIOCON.NS)

-NSE
465.65 Down 14.25(2.97%) Jul 28
Prev Close:479.90
Open:480.00
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:460.50 - 481.00
52wk Range:311.55 - 553.60
Volume:973,597
Avg Vol (3m):1,017,040
Market Cap:91.45B
P/E (ttm):22.37
EPS (ttm):20.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in INR.

Key Statistics

Forward P/E (1 yr):16.48
P/S (ttm):3.25
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Mar-15) :23.66
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):1.64

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biocon Limited develops and sells biotechnology products for the pharmaceutical sector in India and internationally. It offers active pharmaceutical ingredients, including cardiovascular agents, anti-obesity agents, immunosuppressants, opthalmics,... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback